Interleukin 10 drives Staphylococcus aureus imprinting and vaccine failure in murine models via antibody glycosylation
Open Access
- 21 October 2024
- journal article
- editorial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 134 (24)
Abstract
Despite many attempts, there is currently no approved vaccine to prevent Staphylococcus aureus infections. Preclinical vaccination models have failed to predict vaccine efficacy in humans as S . aureus exposure in humans imprints an immune response that is lacking in naive animals. In this issue of the JCI , Tsai and colleagues identify the cytokine IL-10 as the driver of humoral imprinting by S . aureus . Upon vaccination, S . aureus –experienced animals produced copious levels of IL-10, resulting in the hyper-α2,3 sialylation of antibodies, which interfered with the phagocytic-promoting properties of the vaccine-elicited anti– S . aureus antibodies. These findings correlate with the observation that hyperproduction of IL-10 in humans also induces hyper-α2,3 sialylation of antibodies and provide a possible mechanism for previous vaccine failures.Keywords
This publication has 23 references indexed in Scilit:
- Non-protective immune imprint underlies failure of Staphylococcus aureus IsdB vaccineCell Host & Microbe, 2022
- Global burden of bacterial antimicrobial resistance in 2019: a systematic analysisThe Lancet, 2022
- Leukocidins: staphylococcal bi-component pore-forming toxins find their receptorsNature Reviews Microbiology, 2017
- Staphylococcal manipulation of host immune responsesNature Reviews Microbiology, 2015
- Effect of an Investigational Vaccine for Preventing Staphylococcus aureus Infections After Cardiothoracic SurgeryJAMA, 2013
- Intestinal carriage of Staphylococcus aureus: how does its frequency compare with that of nasal carriage and what is its clinical impact?European Journal of Clinical Microbiology & Infectious Diseases, 2008
- Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionalityMolecular Immunology, 2007
- The role of nasal carriage in Staphylococcus aureus infectionsThe Lancet Infectious Diseases, 2005
- Use of aStaphylococcus aureusConjugate Vaccine in Patients Receiving HemodialysisNew England Journal of Medicine, 2002
- Nasal Carriage as a Source ofStaphylococcus aureusBacteremiaNew England Journal of Medicine, 2001